MRI for Ductal Carcinoma
This trial is studying the use of breast MRI in addition to mammography in women who have already been diagnosed with breast cancer to see if it can help find other areas of cancer.
- Ductal Carcinoma in Situ
- Breast Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are octogenarians eligible to participate in this experimental research?
"The trial is available to patients aged between 21 and 59. There are 1439 clinical trials for individuals over the age of 65, as well as 55 studies that accept participants below 18 years old."
Could I be a participant in this clinical experiment?
"For this study, 115 individuals aged 21 to 59 with a diagnosis of breast cancer must meet the following qualifications: under 60 years old at time of agreement signature; Stage 0 or I T1mic upon evaluation; core biopsy results demonstrate DCIS and/or microinvasion (no more than .01 cm); planned surgical intervention completed at MSKCC prior to enrollment; informed consent obtained from participant; female."
Are there any available slots for participants in this research endeavor?
"Per the clinicaltrials.gov listing, this particular research study is not currently open to participants. Initially posted on 10/10/2006 and last updated 11/7/2022, recruitment has temporarily ceased; however, there are still 1,513 other trials welcoming applicants at present."